The kidney from prenatal to adult life: Perinatal programming and reduction of number of nephrons during development

American Journal of Nephrology

Volumn 30, Issue 2, 2009, Pages 162-170

  Puddu, Melania ^a   Fanos, Vassilios ^a,c   Podda, Francesca ^a   Zaffanello, Marco ^b  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c Puericultura Institute   (Italy)

Author keywords

Glomerular hyperfiltration; Intrauterine growth restriction; Nephrons, number of; Perinatal programming; Renal volume

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CEFTRIAXONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IBUPROFEN; INDOMETACIN; VANCOMYCIN;

ACUTE KIDNEY FAILURE; ADULT; ADULTHOOD; ALBUMINURIA; APOPTOSIS; ARTERIAL PRESSURE; CARDIOVASCULAR DISEASE; CELL COUNT; CHRONIC KIDNEY FAILURE; EMBRYO; EMBRYO DEVELOPMENT; ENVIRONMENTAL FACTOR; FETUS; FETUS DEVELOPMENT; GESTATIONAL AGE; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION; HEREDITY; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPOTENSION; INFANT; KIDNEY DEVELOPMENT; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY HYPERTROPHY; LOW BIRTH WEIGHT; NEONATAL ANURIA; NEPHRON; NEPHROTOXICITY; NEWBORN; NONHUMAN; OLIGOHYDRAMNIOS; OLIGURIA; PRENATAL PERIOD; PRIORITY JOURNAL; PROTEINURIA; RENAL DYSGENESIS; REVIEW; RISK FACTOR; SIDE EFFECT;

ANIMALS; CHILD; DEVELOPMENTAL BIOLOGY; EMBRYONIC DEVELOPMENT; FEMALE; HUMANS; HYPERTENSION; KIDNEY; KIDNEY DISEASES; MALE; MODELS, BIOLOGICAL; NEPHRONS; NUTRITIONAL SCIENCES; PREGNANCY; VITAMIN A;

EID: 63349089705     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000211324     Document Type: Review

References (103)

1. Barker DJ, Osmond C, Law CM: The intrauterine and early postnatal origins of cardiovascular disease and chronic bronchitis. J Epidemiol Community Health 1989; 43: 237-240. (Pubitemid 19224131)
2. Barker DJ, Osmond C, Simmonds SJ, Wield GA: The relation of small head circumference and thinness at birth to death from cardiovascular disease in adult life. BMJ 1993; 306: 422-426. (Pubitemid 23045550)
3. Brenner BM, Garcia DL, Anderson S: Glomeruli and blood pressure: less of one, more of the other? Am J Hypertens 1988; 1: 335-347.
4. Keller G, Zimmer G, Mall G, Ritz E, Amann K: Nephron number in patients with primary hypertension. N Engl J Med 2003; 348: 101-108. (Pubitemid 36056716)
5. Cullen-McEwen LA, Kett MM, Dowling J, Anderson WP, Bertram JF: Nephron number, renal function, and arterial pressure in aged GDNF heterozygous mice. Hypertension 2003; 41: 335-340. (Pubitemid 36204911)
6. Giapros V, Drougia A, Hotoura E, Papadopoulou F, Argyropoulou M, Andronikou S: Kidney growth in small-for-gestational-age infants: evidence of early accelerated renal growth. Nephrol Dial Transplant 2006; 21: 3422-3427. (Pubitemid 44817090)
7. Kriz W, LeHir M: Pathways to nephron loss starting from glomerular diseases - insights from animal models. Kidney Int 2005; 67: 404-419. (Pubitemid 40139832)
8. Ingelfinger JR: Is microanatomy destiny? N Engl J Med 2003; 348: 99-100.
9. Rostand SG: Oligonephronia, primary hypertension and renal disease: 'is the child father to the man?' Nephrol Dial Transplant 2003; 18: 1434-1438.
10. Woolf AS, Price KL, Scambler PJ, Winyard PJ: Evolving concepts in human renal dysplasia. J Am Soc Nephrol 2004; 15: 998-1007.
11. Yiu V, Burka S, Zurakowski D, McCormick M, Brenner B, Jabs K: Relationship between birth weight and blood pressure in childhood. Am J Kidney Dis 1999; 33: 253-260. (Pubitemid 29072225)
12. Ingelfinger JR: Disparities in renal endowment: causes and consequences. Adv Chronic Kidney Dis 2008; 15: 107-114.
13. Luyckx VA, Brenner BM: Low birth weight, nephron number, and kidney disease. Kidney Int Suppl 2005:S68-S77. (Pubitemid 43301314)
14. El-Dahr SS, Aboudehen K, Saifudeen Z: Transcriptional control of terminal nephron differentiation. Am J Physiol Renal Physiol 2008; 294:F1273-F1278.
15. Zaffanello M, Brugnara M, Franchini M, Fanos V: TCF2 gene mutation leads to nephrourological defects of unequal severity: an open question. Med Sci Monit 2008; 14: RA78-RA86. (Pubitemid 351929700)
16. Salomon R, Tellier AL, Attie-Bitach T, Amiel J, Vekemans M, Lyonnet S, Dureau P, Niaudet P, Gubler MC, Broyer M: PAX2 mutations in oligomeganephronia. Kidney Int 2001; 59: 457-462.
17. Hohenfellner K, Wingen AM, Nauroth O, Wühl E, Mehls O, Schaefer F: Impact of ACE I/D gene polymorphism on congenital renal malformations. Pediatr Nephrol 2001; 16: 356-361. (Pubitemid 32366671)
18. Dressler GR: Epigenetics, development, and the kidney. J Am Soc Nephrol 2008; 19: 2060-2067.
19. Simeoni U, Boubred F, Buffat C, Vaiman D: The developing kidney and the fetal origins of adult cardiovascular disease; in Oh W, Guignard JP, Baumgart S (eds): Neonatology Questions and Controversies. Nephrology and Fluid/Electrolyte Physiology. Philadelphia, Saunders Elsevier, 2008, pp 97-106.
20. Schwaderer AL, Bates CM, McHugh KM, McBride KL: Renal anomalies in family members of infants with bilateral renal agenesis/ adysplasia. Pediatr Nephrol 2007; 22: 52-56.
21. Hotoura E, Argyropoulou M, Papadopoulou F, Giapros V, Drougia A, Nikolopoulos P, Andronikou S: Kidney development in the first year of life in small-for-gestational-age preterm infants. Pediatr Radiol 2005; 35: 991-994. (Pubitemid 41403489)
22. Amann K, Plank C, Dötsch J: Low nephron number - a new cardiovascular risk factor in children? Pediatr Nephrol 2004; 19: 1319-1323.
23. Hoy WE, Hughson MD, Bertram JF, Douglas-Denton R, Amann K: Nephron number, hypertension, renal disease, and renal failure. J Am Soc Nephrol 2005; 16: 2557-2564.
24. Merlet-Bénichou C, Vilar J, Lelievre-Pegorier M, Moreau E, Gilbert T: Fetal nephron mass: its control and deficit. Adv Nephrol Necker Hosp 1997; 26: 19-45.
25. Merlet-Bénichou C, Gilbert T, Vilar J, Moreau E, Freund N, Lelièvre-Pégorier M: Nephron number: variability is the rule. Causes and consequences. Lab Invest 1999; 79: 515-527.
26. Hinchliffe SA, Lynch MR, Sargent PH, Howard CV, Van Velzen D: The effect of intrauterine growth retardation on the development of renal nephrons. Br J Obstet Gynaecol 1992; 99: 296-301.
27. Hughson M, Farris AB 3rd, Douglas-Denton R, Hoy WE, Bertram JF: Glomerular number and size in autopsy kidneys: the relationship to birth weight. Kidney Int 2003; 63: 2113-2122.
28. Mañalich R, Reyes L, Herrera M, Melendi C, Fundora I: Relationship between weight at birth and the number and size of renal glomeruli in humans: a histomorphometric study. Kidney Int 2000; 58: 770-773. (Pubitemid 30620027)
29. Rodríguez MM, Gómez AH, Abitbol CL, Chandar JJ, Duara S, Zilleruelo GE: Histomorphometric analysis of postnatal glomerulogenesis in extremely preterm infants. Pediatr Dev Pathol 2004; 7: 17-25. (Pubitemid 38520228)
30. Huxley RR, Shiell AW, Law CM: The role of size at birth and postnatal catch-up growth in determining systolic blood pressure: a systematic review of the literature. J Hypertens 2000; 18: 815-831.
31. Zandi-Nejad K, Luyckx VA, Brenner BM: Adult hypertension and kidney disease: the role of fetal programming. Hypertension 2006; 47: 502-508. (Pubitemid 43843866)
32. Gielen M, Pinto-Sietsma SJ, Zeegers MP, Loos RJ, Fagard R, de Leeuw PW, Beunen G, Derom C, Vlietinck R: Birth weight and creatinine clearance in young adult twins: influence of genetic, prenatal, and maternal factors. J Am Soc Nephrol 2005; 16: 2471-2476. (Pubitemid 41725066)
33. Hershkovitz D, Burbea Z, Skorecki K, Brenner BM: Fetal programming of adult kidney disease: cellular and molecular mechanisms. Clin J Am Soc Nephrol 2007; 2: 334-342.
34. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents: The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004; 114: 555-576.
35. Rotteveel J, van Weissenbruch MM, Twisk JW, Delemarre-Van de Waal HA: Infant and childhood growth patterns, insulin sensitivity, and blood pressure in prematurely born young adults. Pediatrics 2008; 122: 313-321.
36. Rodríguez-Soriano J, Aguirre M, Oliveros R, Vallo A: Long-term renal follow-up of extremely low birth weight infants. Pediatr Nephrol 2005; 20: 579-584. (Pubitemid 41166610)
37. Puddu M, Podda MF, Mussap M, Tumbarello R, Fanos V: Early detection of microalbuminuria and hypertension in children of very low birthweight. J Matern Fetal Neonatal Med 2009;22:83-88.
38. Lackland DT, Bendall HE, Osmond C, Egan BM, Barker DJ: Low birth weights contribute to high rates of early-onset chronic renal failure in the southeastern United States. Arch Intern Med 2000; 160: 1472-1476. (Pubitemid 30327450)
39. Hoy WE, Rees M, Kile E, Mathews JD, Wang Z: A new dimension to the Barker hypothesis: low birthweight and susceptibility to renal disease. Kidney Int 1999; 56: 1072-1077. (Pubitemid 29411735)
40. Spencer J, Wang Z, Hoy W: Low birth weight and reduced renal volume in Aboriginal children. Am J Kidney Dis 2001; 37: 915-920. (Pubitemid 32436562)
41. Singh GR, Hoy WE: The association between birthweight and current blood pressure: a cross-sectional study in an Australian Aboriginal community. Med J Aust 2003; 179: 532-535.
42. Abitbol CL, Bauer CR, Montané B, Chandar J, Duara S, Zilleruelo G: Long-term follow-up of extremely low birth weight infants with neonatal renal failure. Pediatr Nephrol 2003; 18: 887-893. (Pubitemid 37121620)
43. Keijzer-Veen MG, Schrevel M, Finken MJ, Dekker FW, Nauta J, Hille ET, Frölich M, van der Heijden BJ; Dutch POPS-19 Collaborative Study Group: Microalbuminuria and lower glomerular filtration rate at young adult age in subjects born very premature and after intrauterine growth retardation. J Am Soc Nephrol 2005; 16: 2762-2768.
44. Schreuder MF: Prenatal programming of nephron number and blood pressure. Kidney Int 2007; 72: 265-268.
45. Keijzer-Veen MG, Kleinveld HA, Lequin MH, Dekker FW, Nauta J, de Rijke YB, van der Heijden BJ: Renal function and size at young adult age after intrauterine growth restriction and very premature birth. Am J Kidney Dis 2007; 50: 542-551. (Pubitemid 47444452)
46. Rakow A, Johansson S, Legnevall L, Sevastik R, Celsi G, Norman M, Vanpée M: Renal volume and function in school-age children born preterm or small for gestational age. Pediatr Nephrol 2008; 23: 1309-1315.
47. Woods LL, Ingelfinger JR, Nyengaard JR, Rasch R: Maternal protein restriction suppresses the newborn renin-angiotensin system and programs adult hypertension in rats. Pediatr Res 2001; 49: 460-467.
48. Boubred F, Buffat C, Feuerstein JM, Daniel L, Tsimaratos M, Oliver C, Lelièvre-Pégorier M, Simeoni U: Effects of early postnatal hypernutrition on nephron number and longterm renal function and structure in rats. Am J Physiol Renal Physiol 2007; 293:F1944-F1949. (Pubitemid 350179619)
49. Bhat PV, Manolescu DC: Role of vitamin A in determining nephron mass and possible relationship to hypertension. J Nutr 2008; 138: 1407-1410.
50. Lelièvre-Pégorier M, Vilar J, Ferrier ML, Moreau E, Freund N, Gilbert T, Merlet-Bénichou C: Mild vitamin A deficiency leads to inborn nephron deficit in the rat. Kidney Int 1998; 54: 1455-1462. (Pubitemid 28502887)
51. Makrakis J, Zimanyi MA, Black MJ: Retinoic acid enhances nephron endowment in rats exposed to maternal protein restriction. Pediatr Nephrol 2007; 22: 1861-1867. (Pubitemid 47506225)
52. Goodyer P, Kurpad A, Rekha S, Muthayya S, Dwarkanath P, Iyengar A, Philip B, Mhaskar A, Benjamin A, Maharaj S, Laforte D, Raju C, Phadke K: Effects of maternal vitamin A status on kidney development: a pilot study. Pediatr Nephrol 2007; 22: 209-214. (Pubitemid 44964321)
53. Quinlan MR, Docherty NG, Watson RW, Fitzpatrick JM: Exploring mechanisms involved in renal tubular sensing of mechanical stretch following ureteric obstruction. Am J Physiol Renal Physiol 2008; 295:F1-F11.
54. Chevalier RL: Pathogenesis of renal injury in obstructive uropathy. Curr Opin Pediatr 2006; 18: 153-160.
55. Chevalier RL, Thornhill BA, Chang AY: Unilateral ureteral obstruction in neonatal rats leads to renal insufficiency in adulthood. Kidney Int 2000; 58: 1987-1995. (Pubitemid 30807927)
56. Chevalier RL, Thornhill BA, Chang AY, Cachat F, Lackey A: Recovery from release of ureteral obstruction in the rat: relationship to nephrogenesis. Kidney Int 2002; 61: 2033-2043. (Pubitemid 34539321)
57. Thornhill BA, Burt LE, Chen C, Forbes MS, Chevalier RL: Variable chronic partial ureteral obstruction in the neonatal rat: a new model of ureteropelvic junction obstruction. Kidney Int 2005; 67: 42-52. (Pubitemid 40019224)
58. Stock JA, Krous HF, Heffernan J, Packer M, Kaplan GW: Correlation of renal biopsy and radionuclide renal scan differential function in patients with unilateral ureteropelvic junction obstruction. J Urol 1995; 154: 716-718.
59. Murer L, Benetti E, Centi S, Della Vella M, Artifoni L, Capizzi A, Zucchetta P, Del Prete D, Carasi C, Montini G, Rigamonti W, Zaccello G: Clinical and molecular markers of chronic interstitial nephropathy in congenital unilateral ureteropelvic junction obstruction. J Urol 2006; 176: 2668-2673. (Pubitemid 44755071)
60. Boubaker A, Meyrat B, Frey P, Bischof Delaloye A: Unilateral urinary flow impairment at the pelviureteral junction: outcome of renal function with respect to therapeutic strategy. Urology 2003; 61: 1224-1228. (Pubitemid 36694007)
61. Zaffanello M, Cecchetto M, Brugnara M, Martone E, Zuffante M, Fedrizzi M, Fanos V: Pelvi-ureteric junction obstruction and renal function after pyeloplasty: a retrospective study in 29 children. Minerva Urol Nefrol 2008; 60: 1-6. (Pubitemid 351701061)
62. Assael BM, Guez S, Marra G, Secco E, Manzoni G, Bosio M, Pelegatta A, Acerbi L, delli Agnola CA, Selvaggio G, Vegni M, Cecchetti V, Cucchi L: Congenital reflux nephropathy: a follow-up of 108 cases diagnosed perinatally. Br J Urol 1998; 82: 252-257.
63. Zaffanello M, Brugnara M, Cecchetto M, Fedrizzi M, Fanos V: Renal involvement in children with vesicoureteral reflux: are prenatal detection and surgical approaches preventive? Scand J Urol Nephrol 2008; 42: 330-336.
64. Cataldi L, Leone R, Moretti U, De Mitri B, Fanos V, Ruggeri L, Sabatino G, Torcasio F, Zanardo V, Attardo G, Riccobene F, Martano C, Benini D, Cuzzolin L: Potential risk factors for the development of acute renal failure in preterm newborn infants: a case-control study. Arch Dis Child Fetal Neonatal Ed 2005; 90:F514-F519. (Pubitemid 41565317)
65. Nathanson S, Moreau E, Merlet-Benichou C, Gilbert T: In utero and in vitro exposure to beta-lactams impair kidney development in the rat. J Am Soc Nephrol 2000; 11: 874-884.
66. Gilbert T, Gaonach S, Moreau E, Merlet-Benichou C: Defect of nephrogenesis induced by gentamicin in rat metanephric organ culture. Lab Invest 1994; 70: 656-666. (Pubitemid 24181178)
67. Smaoui H, Schaeverbeke M, Mallié JP, Schaeverbeke J: Transplacental effects of gentamicin on endocytosis in rat renal proximal tubule cells. Pediatr Nephrol 1994; 8: 447-450. (Pubitemid 24228638)
68. Kent AL, Maxwell LE, Koina ME, Falk MC, Willenborg D, Dahlstrom JE: Renal glomeruli and tubular injury following indomethacin, ibuprofen, and gentamicin exposure in a neonatal rat model. Pediatr Res 2007; 62: 307-312. (Pubitemid 47301480)
69. Giapros V, Papadimitriou P, Challa A, Andronikou S: The effect of intrauterine growth retardation on renal function in the first two months of life. Nephrol Dial Transplant 2007; 22: 96-103. (Pubitemid 46050333)
70. Fanos V, Cataldi L: Antibacterial-induced nephrotoxicity in the newborn. Drug Saf 1999; 20: 245-267.
71. Fanos V, Cuzzolin L, Atzei A, Testa M: Antibiotics and antifungals in neonatal intensive care units: a review. J Chemother 2007; 19: 5-20. (Pubitemid 46255467)
72. Cuzzolin L, Dal Cerè M, Fanos V: NSAID-induced nephrotoxicity from the fetus to the child. Drug Saf 2001; 24: 9-18.
73. van der Heijden BJ, Carlus C, Narcy F, Bavoux F, Delezoide AL, Gubler MC: Persistent anuria, neonatal death, and renal microcystic lesions after prenatal exposure to indomethacin. Am J Obstet Gynecol 1994; 171: 617-623. (Pubitemid 24312339)
74. Norton ME, Merrill J, Cooper BA, Kuller JA, Clyman RI: Neonatal complications after the administration of indomethacin for preterm labor. N Engl J Med 1993; 329: 1602-1607. (Pubitemid 23345638)
75. Kaplan BS, Restaino I, Raval DS, Gottlieb RP, Bernstein J: Renal failure in the neonate associated with in utero exposure to nonsteroidal anti-inflammatory agents. Pediatr Nephrol 1994; 8: 700-704.
76. Cuzzolin L, Fanos V, Pinna B, di Marzio M, Perin M, Tramontozzi P, Tonetto P, Cataldi L: Postnatal renal function in preterm newborns: a role of diseases, drugs and therapeutic interventions. Pediatr Nephrol 2006; 21: 931-938. (Pubitemid 43885090)
77. Hasan J, Beharry KD, Gharraee Z, Stavitsky Y, Abad-Santos P, Abad-Santos M, Aranda JV, Modanlou HD: Early postnatal ibuprofen and indomethacin effects in suckling and weanling rat kidneys. Prostaglandins Other Lipid Mediat 2008; 85: 81-88.
78. Landau D, Shelef I, Polacheck H, Marks K, Holcberg G: Perinatal vasoconstrictive renal insufficiency associated with maternal nimesulide use. Am J Perinatol 1999; 16: 441-444. (Pubitemid 30196909)
79. Peruzzi L, Gianoglio B, Porcellini MG, Coppo R: Neonatal end-stage renal failure associated with maternal ingestion of cyclo-oxygenase-type-1 selective inhibitor nimesulide as tocolytic. Lancet 1999; 354: 1615. (Pubitemid 29515961)
80. Benini D, Fanos V, Cuzzolin L, Tatò L: In utero exposure to nonsteroidal anti-inflammatory drugs: neonatal renal failure. Pediatr Nephrol 2004; 19: 232-234.
81. Boubred F, Vendemmia M, Garcia-Meric P, Buffat C, Millet V, Simeoni U: Effects of maternally administered drugs on the fetal and neonatal kidney. Drug Saf 2006; 29: 397-419. (Pubitemid 43752542)
82. Buttar HS: An overview of the influence of ACE inhibitors on fetal-placental circulation and perinatal development. Mol Cell Biochem 1997; 176: 61-71.
83. Schubiger G, Flury G: Enalapril for pregnancy-induced hypertension: acute renal failure in a neonate. Ann Intern Med 1988; 108: 215-216.
84. Rosa F, Bosco L, Fossum C: Neonatal anuria with maternal angiotensin-converting enzyme inhibition. Obstet Gynecol 1989; 74: 371-374. (Pubitemid 19213925)
85. Cunniff C, Jones KL, Phillipson J: Oligohydramnios sequence and renal tubular malformation associated with maternal enalapril use. Am J Obstet Gynecol 1990; 162: 187-189. (Pubitemid 20055447)
86. Bhatt-Mehta V, Deluga KS: Fetal exposure to lisinopril: neonatal manifestations and management. Pharmacotherapy 1993; 13: 515-518. (Pubitemid 23301978)
87. Shatan A, Widerhorn J, Hurst A: Risk of angiotensin-converting enzyme inhibition during pregnancy: experimental and clinical evidence, potential mechanisms, and recommendations for use. Am J Med 1994; 96: 451-456. (Pubitemid 24156732)
88. Filler G, Wong H, Condello AS, Charbonneau C, Sinclair B, Kovesi T, Hutchison J: Early diagnosis in a neonate with intrauterine lisinopril exposure. Arch Dis Child Fetal Neonatal Ed 2003; 88:F154-F156. (Pubitemid 36269541)
89. Murki S, Kumar P, Dutta S, Narang A: Fatal neonatal renal failure due to maternal enalapril ingestion. Matern Fetal Neonatal Med 2005; 17: 235-237. (Pubitemid 40992346)
90. Tabacova S, Little R, Tsong Y, Vega A, Kimmel CA: Adverse pregnancy outcomes associated with maternal enalapril antihypertensive treatment. Pharmacoepidemiol Drug Saf 2003; 12: 633-646. (Pubitemid 38028777)
91. Shrim A, Berger H, Kingdom J, Hamoudi A, Shah PS, Koren G: Prolonged exposure to angiotensin-converting enzyme inhibitors during pregnancy. Fetal toxicity could be reversible. Can Fam Physician 2005; 51: 1335-1337.
92. Cooper WO, Hernandez-Diaz S, Arbogast PG, Dudley JA, Dyer S, Gideon PS, Hall K, Ray WA: Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 2006; 354: 2443-2451. (Pubitemid 43855047)
93. Lambot MA, Vermeylen D, Noël JC: Angiotensin-II-receptor inhibitors in pregnancy. Lancet 2001; 357: 1619-1620.
94. Alwan S, Polifka JE, Friedman JM: Angiotensin II receptor antagonist treatment during pregnancy. Birth Defects Res A Clin Mol Teratol 2005; 73: 123-130. (Pubitemid 40289535)
95. Zaffanello M, Franchini M, Fanos V: Is serum cystatin-C a suitable marker of renal function in children? Ann Clin Lab Sci 2007; 37: 233-240.
96. Safak AA, Simsek E, Bahcebasi T: Sonographic assessment of the normal limits and percentile curves of liver, spleen, and kidney dimensions in healthy school-aged children. J Ultrasound Med 2005; 24: 1359-1364. (Pubitemid 41395923)
97. Vujic A, Kosutic J, Bogdanovic R, Prijic S, Milicic B, Igrutinovic Z: Sonographic assessment of normal kidney dimensions in the first year of life - a study of 992 healthy infants. Pediatr Nephrol 2007; 22: 1143-1150.
98. Riccabona M, Fritz G, Schollnast H, Schwarz T, Deutschmann MJ, Mache CJ: Hydronephrotic kidney: pediatric three-dimensional US for relative renal size assessment - initial experience. Radiology 2005; 236: 276-283. (Pubitemid 40853323)
99. Kim HC, Yang DM, Lee SH, Cho YD: Usefulness of renal volume measurements obtained by a 3-dimensional sonographic transducer with matrix electronic arrays. J Ultrasound Med 2008; 27: 1673-1681.
100. Zaffanello M, Franchini M, Fanos V: New therapeutic strategies with combined renin-angiotensin system inhibitors for pediatric nephropathy. Pharmacotherapy 2008; 28: 125-130.
101. Eskild-Jensen A, Paulsen LF, Wogensen L, Olesen P, Pedersen L, Frøkiaer J, Nyengaard JR: AT1 receptor blockade prevents interstitial and glomerular apoptosis but not fibrosis in pigs with neonatal induced partial unilateral ureteral obstruction. Am J Physiol Renal Physiol 2007; 292:F1771-F1781.
102. Shirazi M, Noorafshan A, Bahri MA, Tanideh N: Captopril reduces interstitial renal fibrosis and preserves more normal renal tubules in neonatal dogs with partial urethral obstruction: a preliminary study. Urol Int 2007; 78: 173-177. (Pubitemid 46239139)
103. Fanos V, Cuzzolin L: Causes and manifestation of nephrotoxicity; in Geary DF, Shaefer F (eds): Comprehensive Pediatric Nephrology. Philadelphia, Mosby Elsevier, 2008, pp 1003-1006.